Terug
Dagbereik
€ 25,08
€ 26,19
52-Weeksbereik
€ 14,59
€ 44,28
Volume
251.123
50D / 200D Gem.
€ 33,34
/
€ 27,63
Vorige Slotkoers
€ 25,35
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -31,1 | 0,3 |
| P/B | 1,6 | 3,0 |
| ROE % | -5,2 | 3,7 |
| Net Margin % | -7,0 | 3,8 |
| Rev Growth 5Y % | 38,3 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 49,80
+97.1%
Low: € 47,00
High: € 52,00
Forward WPA
-€ 1,18
Omzet Sch.
345,63M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,02
€ 1,01 – € 1,03
|
505,55M | 1 |
| FY2029 |
€ 0,57
€ 0,56 – € 0,57
|
466,65M | 1 |
| FY2028 |
-€ 0,03
-€ 0,36 – € 0,31
|
433,73M | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -€ 0,26 | -€ 0,08 | +69,1% |
| 2025-11-03 | -€ 0,34 | -€ 0,02 | +94,1% |
| 2025-08-04 | -€ 0,51 | € 0,15 | +129,4% |
| 2025-05-05 | -€ 0,08 | -€ 0,20 | -150,0% |
| 2025-02-27 | -€ 0,04 | € 0,32 | +900,0% |
| 2024-11-04 | -€ 0,06 | € 0,08 | +233,3% |
| 2024-08-05 | -€ 0,27 | € 0,31 | +214,8% |
| 2024-05-02 | -€ 0,37 | -€ 0,09 | +75,7% |
Insider Trading Activity
Buy ratio (90d)
0.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 |
Stokes Frank
Chief Financial Officer
|
sell | 6.001 | € 27,98 | € 167.907,98 |
| Jan 12, 2026 |
Stokes Frank
Chief Financial Officer
|
grant | 16.248 | — | — |
| Dec 17, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 14.888 | € 39,31 | € 585.291,94 |
| Dec 11, 2025 |
Stokes Frank
Chief Financial Officer
|
sell | 4.496 | € 37,45 | € 168.375,20 |
| Dec 10, 2025 |
Stokes Frank
Chief Financial Officer
|
other | 15.098 | — | — |
| Dec 10, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
other | 14.892 | — | — |
| Dec 9, 2025 |
Stokes Frank
Chief Financial Officer
|
other | 35.766 | — | — |
| Dec 9, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
other | 36.613 | — | — |
| Nov 11, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 18.932 | € 35,10 | € 664.513,20 |
| Nov 11, 2025 |
Stokes Frank
Chief Financial Officer
|
sell | 5.388 | € 35,08 | € 189.011,04 |
| Oct 31, 2025 |
Oelschlager Kristen M
Chief Operating Officer
|
sell | 12.678 | € 25,04 | € 317.457,12 |
| Aug 8, 2025 |
Juvenal Tobin W
Chief Commercial Officer
|
other | 25.574 | — | — |
| May 22, 2025 |
Harrison Miles
Director
|
grant | 13.667 | — | — |
| May 22, 2025 |
Cole G Bradley
Director
|
grant | 13.667 | — | — |
| May 22, 2025 |
Caple Kim
Director
|
grant | 13.667 | — | — |
| May 22, 2025 |
Cotton Rodney
Director
|
grant | 13.667 | — | — |
| May 21, 2025 |
Harrison Miles
Director
|
other | 17.346 | — | — |
| May 21, 2025 |
Cole G Bradley
Director
|
other | 17.346 | — | — |
| May 21, 2025 |
Caple Kim
Director
|
other | 17.346 | — | — |
| May 21, 2025 |
Cotton Rodney
Director
|
other | 17.346 | — | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 38,30% annually over 5 years — strong growth
Earnings declined -232,41% over the past year
Debt/Equity of 0,08 — conservative balance sheet
Generating 28,33M in free cash flow
PEG of 0,21 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 34,64%
Groei
Revenue Growth (5Y)
38,30%
Revenue (1Y)3,66%
Earnings (1Y)-232,41%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-5,21%
ROIC-6,32%
Net Margin-7,02%
Op. Margin-12,44%
Veiligheid
Debt / Equity
0,08
Current Ratio5,26
Interest Coverage-497,79
Waardering
P/E Ratio
-31,10
Forward P/EN/A
P/B Ratio1,60
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,66% | Revenue Growth (3Y) | 25,15% |
| Earnings Growth (1Y) | -232,41% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38,30% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 344,23M | Net Income (TTM) | -24,16M |
| ROE | -5,21% | ROA | -4,18% |
| Gross Margin | 68,66% | Operating Margin | -12,44% |
| Net Margin | -7,02% | Free Cash Flow (TTM) | 28,33M |
| ROIC | -6,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 5,26 |
| Interest Coverage | -497,79 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -31,10 | Forward P/E | N/A |
| P/B Ratio | 1,60 | P/S Ratio | 2,18 |
| PEG Ratio | 0,21 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2,17 | Fwd Earnings Yield | N/A |
| FCF Yield | 3,77% | ||
| Market Cap | 751,31M | Enterprise Value | 671,49M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 344,23M | 332,07M | 219,79M | 137,04M | 94,09M |
| Net Income | -24,16M | 18,25M | -57,47M | -67,14M | -31,29M |
| EPS (Diluted) | -0,83 | 0,62 | -2,14 | -2,58 | -1,24 |
| Gross Profit | 236,35M | 271,86M | 174,81M | 105,03M | 78,26M |
| Operating Income | -42,81M | 8,67M | -67,98M | -72,86M | -40,08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 578,56M | 531,24M | 453,34M | 447,33M | 462,57M |
| Total Liabilities | 107,68M | 75,40M | 62,07M | 48,18M | 50,83M |
| Shareholders' Equity | 470,87M | 455,84M | 391,27M | 399,15M | 411,74M |
| Total Debt | 36,91M | 26,34M | 15,34M | 13,40M | 8,20M |
| Cash & Equivalents | 116,73M | 119,71M | 98,84M | 122,95M | 329,63M |
| Current Assets | 361,10M | 360,15M | 295,64M | 292,29M | 353,74M |
| Current Liabilities | 68,68M | 49,39M | 47,67M | 36,13M | 24,89M |